secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
CIK:        0001100682
Form:       8-K
Filed at:   2026-05-11T21:01:28+00:00
Accession:  0000950103-26-007060
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CRL shareholders approve 2026 LTIP, re-elect all 12 directors
-------------------------------------------------------------

- 2026 Long-Term Incentive Plan approved with 41.5M for vs 2.6M against; 4.825M shares authorized.
- All 12 director nominees elected; Abraham Ceesay received highest withhold (8.3M against).
- Advisory say-on-pay passed with 41.4M for vs 2.7M against, 1.7M broker non-votes.
- Ratification of PricewaterhouseCoopers as auditor approved with 43.6M for vs 2.2M against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1100682/000095010326007060/0000950103-26-007060-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1100682/000095010326007060/dp246529_8k.htm
  HTML page:      https://secwatch.observer/filing/0000950103-26-007060

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer